TrialViruses2023

Safety and Immunogenicity of Inactivated Whole Virion COVID-19 Vaccine CoviVac in Clinical Trials in 18-60 and 60+ Age Cohorts.

Ilya V Gordeychuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.